Daratumumab in Treating Patients With Multiple Myeloma
Clinical trial NCT02944565 · COMPLETED
Trial details
- NCT number
- NCT02944565
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-22
- Primary completion
- 2017-07-20
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.